MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree

    P. Bogdanova-Mihaylova, N. Austin, M.D. Alexander, L. Cassidy, S.M. Murphy, R.A. Walsh (Dublin, Ireland)

    Objective: We report on a family with ataxia due to mutations in the ANO10 gene to provide comprehensive clinical and cognitive data on the associated…
  • 2016 International Congress

    Clinical and imaging characteristics of spinocerebellar ataxia type 14 defined in a German multi-center sample

    T. Schmitz-Hübsch, S. Lux, A.U. Brandt, P. Bauer, E. Schlapakow, S. Greschus, H. Gärtner, M.E. Kirlangic, V. Gras, D. Timmann, M. Synofzik, N. Shah, L. Schöls, U. Kopp, T. Oberwahrenbrock, H. Zimmermann, C. Pfueller, E.M. Kadas, M. Rönnefarth, A. Grosch, M. Endres, T. Klockgether, K. Amunts, F. Paul, S. Doss, M. Minnerop (Berlin, Germany)

    Objective: To give a concise description of clinical and imaging features of spinocerebellar ataxia type 14 (SCA14). Background: Since its genetic definition in 2003, the…
  • 2016 International Congress

    A randomized double-blind placebo- and positive-controlled crossover study to evaluate the effects of single doses of SD-809 (deutetrabenazine) and tetrabenazine on the corrected QT interval

    D. Stamler, E. Offman, M. Bradbury, L. De Boer (La Jolla, CA, USA)

    Objective: Evaluate the pharmacokinetics and pharmacodynamics (QTc) of SD-809 (deutetrabenazine) and tetrabenazine. Background: SD-809 is a VMAT-2 inhibitor in clinical development for treatment of hyperkinetic…
  • 2016 International Congress

    Dysregulations of GABAergic neurotransmission in Huntington’s disease brain

    Y.T. Hsu, Y.G. Chang, H.M. Chen, Y. Chern (Taichung, Taiwan)

    Objective: To investigate (1) the expression of GABAA receptors and KCC2 in both Huntington's disease (HD) mouse models and patients and (2) the inhibitory effect…
  • 2016 International Congress

    Enroll-HD: A global clinical research platform for Huntington’s disease

    T.A. Mestre, C. Fitzer-Attas, J. Giuliano, B. Landwehrmeyer, C. Sampaio (Ottawa, Canada)

    Objective: To provide an update on the global observational registry study of Huntington's disease (HD) included in Enroll-HD, a platform for HD clinical research. Background:…
  • 2016 International Congress

    Brain network imaging findings in multiple system atrophy with cognitive decline

    K. Hara, H. Watanabe, E. Bagarinao, K. Kawabata, N. Yoneyama, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: In this study we examined the voxel-based morphometry (VBM), diffusion tensor imaging (DTI), and resting functional MRI (rsfMRI) of the multiple system atrophy (MSA)…
  • 2016 International Congress

    Frontal lobe white matter atrophy correlates with disability in spastic paraplegia type 11 (SPG11)

    I. Faber, A.R.M. Martinez, T.T.J. Rezende, R.F. Casseb, C.M. Lourenço, W. Marques Jr, J.L. Pedroso, O.G.P. Barsottini, I.T. Lopes-Cendes, M.C. França Jr (Campinas, Brazil)

    Objective: To evaluate in vivo signs of gray matter (GM) and white matter (WM) abnormalities, through an unbiased neuroimaging method, in a large cohort of…
  • 2016 International Congress

    Inferring the causal interplay of motor related brain areas in the aging brain: A dynamic causal modeling (DCM) approach

    F. Jung, P. Löhrer, F. Nettersheim, I. Weber, T.A. Dembek, C. Huber, E.A. Pelzer, M. Tittgemeyer, L. Timmermann (Cologne (Köln), Germany)

    Objective: To investigate the causal interplay of brain areas during the performance of a complex bimanual motor task in young and elderly subjects. Background: Coordination…
  • 2016 International Congress

    Resting state functional connectivity in olfactory network in de novo Parkinson’s disease

    S. Marino, L. Bonanno, F. Caminiti, F. Corallo, V. Lo Buono, S. De Salvo, G. Di Lorenzo, P. Bramanti (Messina, Italy)

    Objective: To assess the pattern of RS functional connectivity in PD patients, related to olfactory psychometric test, to elucidate olfactory-dependent cortical-subcortical functional networks. Background: Olfactory…
  • 2016 International Congress

    Predictive performance of EEG theta spectral power over developing dementia in Parkinson’s disease

    V.V. Cozac, M. Chaturvedi, U. Gschwandtner, F. Hatz, A. Meyer, K. Nowak, R. Sturzenegger, P. Fuhr (Basel, Switzerland)

    Objective: To investigate whether changes in EEG power spectra could predict development of dementia in Parkinson's disease (PD-D). Background: Different research groups have reported, that…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley